Open Access

IL‑10 secreted by cancer‑associated macrophages regulates proliferation and invasion in gastric cancer cells via c‑Met/STAT3 signaling

  • Authors:
    • Ling Chen
    • Yuntao Shi
    • Xiaojuan Zhu
    • Weiwei Guo
    • Mingjiong Zhang
    • Ying Che
    • Lijuan Tang
    • Xiaozhong Yang
    • Qiang You
    • Zheng Liu
  • View Affiliations

  • Published online on: June 19, 2019     https://doi.org/10.3892/or.2019.7206
  • Pages: 595-604
  • Copyright: © Chen et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Gastric cancer is one of the most common types of human cancer, and it is additionally one of the leading causes of cancer‑associated mortality worldwide. Previous studies have suggested that interleukin (IL)‑10 may contribute to the pathogenesis of gastric cancer. However, the underlying mechanisms remain unclear. In the present study, it was observed that the expression of IL‑10 was significantly upregulated in gastric tumor tissues and serum samples of patients with gastric cancer. Furthermore, IL‑10 was increased in the cell culture supernatant of cancer‑associated macrophages (CAMs). Treatment with cell culture supernatant from CAMs induced a significant increase in proliferation and migration, while it suppressed apoptosis, in MGC‑803 and BGC‑823 gastric cancer cells. Notably, application of an inhibitory IL‑10 antibody partially blocked the cell culture supernatant of CAM‑induced oncogenic effects. RNA‑sequencing analysis was then performed to identify the differentially expressed genes in MGC‑803 cells treated with IL‑10. Based on the sequencing results and in vitro analysis, it was demonstrated that IL‑10‑induced carcinogenic behaviors in MGC‑803 cells were potentially mediated by activation of the c‑Met/STAT3 signaling pathway. In conclusion, the present results demonstrated that IL‑10 secreted by CAMs may be involved in the pathogenesis of gastric cancer, suggesting that IL‑10 may serve as a potential therapeutic target for the treatment of gastric cancer.

References

1 

Yao Q, Tu C, Lu D, Zou Y, Liu H and Zhang S: Clinicopathological significance of the microRNA-146a/WASP-family verprolin-homologous protein-2 axis in gastric cancer. Cancer Sci. 108:1285–1292. 2017. View Article : Google Scholar : PubMed/NCBI

2 

Zhang DY, Wang J, Zhang GQ, Chu XQ, Zhang JL and Zhou Y: Correlations of MMP-2 and TIMP-2 gene polymorphisms with the risk and prognosis of gastric cancer. Int J Exp Med. 8:20391–20401. 2015.

3 

Zhu X, Tian X, Yu C, Shen C, Yan T, Hong J, Wang Z, Fang JY and Chen H: A long non-coding RNA signature to improve prognosis prediction of gastric cancer. Mol Cancer. 15:602016. View Article : Google Scholar : PubMed/NCBI

4 

Sakamoto N, Tsujimoto H, Takahata R, Cao B, Zhao P, Ito N, Shimazaki H, Ichikura T, Hase K, Vande Woude GF and Shinomiya N: MET4 expression predicts poor prognosis of gastric cancers with Helicobacter pylori infection. Cancer Sci. 108:322–330. 2017. View Article : Google Scholar : PubMed/NCBI

5 

Higuchi K, Inokuchi M, Takagi Y, Ishikawa T, Otsuki S, Uetake H, Kojima K and Kawano T: Cadherin 5 expression correlates with poor survival in human gastric cancer. J Clin Pathol. 70:217–221. 2017. View Article : Google Scholar : PubMed/NCBI

6 

Mosser DM and Zhang X: Interleukin-10: New perspectives on an old cytokine. Immunol Rev. 226:205–218. 2008. View Article : Google Scholar : PubMed/NCBI

7 

Pereira L, Font-Nieves M, Van den Haute C, Baekelandt V, Planas AM and Pozas E: IL-10 regulates adult neurogenesis by modulating ERK and STAT3 activity. Front Cell Neurosci. 9:572015. View Article : Google Scholar : PubMed/NCBI

8 

Liu BS, Cao Y, Huizinga TW, Hafler DA and Toes RE: TLR-mediated STAT3 and ERK activation controls IL-10 secretion by human B cells. Eur J Immunol. 44:2121–2129. 2014. View Article : Google Scholar : PubMed/NCBI

9 

Chen D, Xie J, Fiskesund R, Dong W, Liang X, Lv J, Jin X, Liu J, Mo S, Zhang T, et al: Chloroquine modulates antitumor immune response by resetting tumor-associated macrophages toward M1 phenotype. Nat Commun. 9:8732018. View Article : Google Scholar : PubMed/NCBI

10 

Ohno Y, Toyoshima Y, Yurino H, Monma N, Xiang H, Sumida K, Kaneumi S, Terada S, Hashimoto S, Ikeo K, et al: Lack of interleukin-6 in the tumor microenvironment augments type-1 immunity and increases the efficacy of cancer immunotherapy. Cancer Sci. 108:1959–1966. 2017. View Article : Google Scholar : PubMed/NCBI

11 

Lan C, Huang X, Lin S, Huang H, Cai Q, Wan T, Lu J and Liu J: Expression of M2-polarized macrophages is associated with poor prognosis for advanced epithelial ovarian cancer. Technol Cancer Res Treat. 12:259–267. 2013. View Article : Google Scholar : PubMed/NCBI

12 

Herrera M, Herrera A, Domínguez G, Silva J, García V, García JM, Gómez I, Soldevilla B, Muñoz C, Provencio M, et al: Cancer-associated fibroblast and M2 macrophage markers together predict outcome in colorectal cancer patients. Cancer Sci. 104:437–444. 2013. View Article : Google Scholar : PubMed/NCBI

13 

Liu JY, Peng CW, Yang GF, Hu WQ, Yang XJ, Huang CQ, Xiong B and Li Y: Distribution pattern of tumor associated macrophages predicts the prognosis of gastric cancer. Oncotarget. 8:92757–92769. 2017.PubMed/NCBI

14 

Yin S, Huang J, Li Z, Zhang J, Luo J, Lu C and Xu H and Xu H: The prognostic and clinicopathological significance of tumor-associated macrophages in patients with gastric cancer: A meta-analysis. PLoS One. 12:e01700422017. View Article : Google Scholar : PubMed/NCBI

15 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI

16 

Salvi A, Abeni E, Portolani N, Barlati S and De Petro G: Human hepatocellular carcinoma cell-specific miRNAs reveal the differential expression of miR-24 and miR-27a in cirrhotic/non-cirrhotic HCC. Int J Oncol. 42:391–402. 2013. View Article : Google Scholar : PubMed/NCBI

17 

Benjamini Y and Hochberg Y: Controlling the false discovery rate: A practical and powerful approach to multiple testing. J R Statist Soc Ser B. 57:289–300. 1995.

18 

He F, Ai B and Tian L: Identification of genes and pathways in esophageal adenocarcinoma using bioinformatics analysis. Biomed Rep. 9:305–312. 2018.PubMed/NCBI

19 

Wu JC, Wang CT, Hung HC, Wu WJ, Wu DC, Chang MC, Sung PJ, Chou YW, Wen ZH and Tai MH: Heteronemin is a novel c-Met/STAT3 inhibitor against advanced prostate cancer cells. Prostate. 76:1469–1483. 2016. View Article : Google Scholar : PubMed/NCBI

20 

Syed ZA, Yin W, Hughes K, Gill JN, Shi R and Clifford JL: HGF/c-met/Stat3 signaling during skin tumor cell invasion: Indications for a positive feedback loop. BMC Cancer. 11:1802011. View Article : Google Scholar : PubMed/NCBI

21 

Ding H, Zhao L, Dai S, Li L, Wang F and Shan B: CCL5 secreted by tumor associated macrophages may be a new target in treatment of gastric cancer. Biomed Pharmacother. 77:142–149. 2016. View Article : Google Scholar : PubMed/NCBI

22 

Yamaguchi T, Fushida S, Yamamoto Y, Tsukada T, Kinoshita J, Oyama K, Miyashita T, Tajima H, Ninomiya I, Munesue S, et al: Tumor-associated macrophages of the M2 phenotype contribute to progression in gastric cancer with peritoneal dissemination. Gastric Cancer. 19:1052–1065. 2016. View Article : Google Scholar : PubMed/NCBI

23 

Gholamin S, Fiuji H, Maftouh M, Mirhafez R, Shandiz FH and Avan A: Targeting c-MET/HGF signaling pathway in upper gastrointestinal cancers: Rationale and progress. Curr Drug Targets. 15:1302–1311. 2014. View Article : Google Scholar : PubMed/NCBI

24 

Marano L, Chiari R, Fabozzi A, De Vita F, Boccardi V, Roviello G, Petrioli R, Marrelli D, Roviello F and Patriti A: C-Met targeting in advanced gastric cancer: An open challenge. Cancer Lett. 365:30–36. 2015. View Article : Google Scholar : PubMed/NCBI

25 

Ding X, Ji J, Jiang J, Cai Q, Wang C, Shi M, Yu Y, Zhu Z and Zhang J: HGF-mediated crosstalk between cancer-associated fibroblasts and MET-unamplified gastric cancer cells activates coordinated tumorigenesis and metastasis. Cell Death Dis. 9:8672018. View Article : Google Scholar : PubMed/NCBI

26 

Okamoto W, Okamoto I, Arao T, Yanagihara K, Nishio K and Nakagawa K: Differential roles of STAT3 depending on the mechanism of STAT3 activation in gastric cancer cells. Br J Cancer. 105:407–412. 2011. View Article : Google Scholar : PubMed/NCBI

27 

Wei X, Juan ZX, Min FX, Nan C, Hua ZX, Qing FZ and Zheng L: Recombinant immunotoxin anti-c-Met/PE38KDEL inhibits proliferation and promotes apoptosis of gastric cancer cells. J Exp Clin Cancer Res. 30:672011. View Article : Google Scholar : PubMed/NCBI

28 

Ries CH, Cannarile MA, Hoves S, Benz J, Wartha K, Runza V, Rey-Giraud F, Pradel LP, Feuerhake F, Klaman I, et al: Targeting tumor-associated macrophages with anti-CSF-1R antibody reveals a strategy for cancer therapy. Cancer Cell. 25:846–859. 2014. View Article : Google Scholar : PubMed/NCBI

Related Articles

Journal Cover

August 2019
Volume 42 Issue 2

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Chen, L., Shi, Y., Zhu, X., Guo, W., Zhang, M., Che, Y. ... Liu, Z. (2019). IL‑10 secreted by cancer‑associated macrophages regulates proliferation and invasion in gastric cancer cells via c‑Met/STAT3 signaling. Oncology Reports, 42, 595-604. https://doi.org/10.3892/or.2019.7206
MLA
Chen, L., Shi, Y., Zhu, X., Guo, W., Zhang, M., Che, Y., Tang, L., Yang, X., You, Q., Liu, Z."IL‑10 secreted by cancer‑associated macrophages regulates proliferation and invasion in gastric cancer cells via c‑Met/STAT3 signaling". Oncology Reports 42.2 (2019): 595-604.
Chicago
Chen, L., Shi, Y., Zhu, X., Guo, W., Zhang, M., Che, Y., Tang, L., Yang, X., You, Q., Liu, Z."IL‑10 secreted by cancer‑associated macrophages regulates proliferation and invasion in gastric cancer cells via c‑Met/STAT3 signaling". Oncology Reports 42, no. 2 (2019): 595-604. https://doi.org/10.3892/or.2019.7206